As RNA pipelines mature, delivery success demands shared benchmarks. This article proposes standardized, stage-specific metrics to compare platforms, guide optimization, and strengthen regulatory confidence.
- Advances In Endometrial-Targeted Drug Delivery In Women's Health
- RNA Delivery Technologies: Industrial Applications And Emerging Innovations
- Why In Vivo Therapies Fail When We Treat Them Like Ex Vivo Ones
- 4 Opportunities For Advancing Drug Delivery
- In Vivo's Biggest Threat — Comparison To Old Models
- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Conducting A Medical Device Stability Study: A Practical Guide
- Nanotechnology Drug Delivery: A Market Overview
ON-DEMAND WEBINARS
Various animal models — including non-human primates, rabbits, minipigs, and canines — present benefits and limitations for preclinical studies. Explore the insights to optimize the path to clinical trials.
We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.
What technical issues need to be addressed if an API is to be successfully micronized? Explore a robust process development strategy that ensures all attributes critical for quality are maintained.
Explore the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-1191001266-tablet-pill]( "How Approved Drugs Have Evolved Since The '70s")
How Approved Drugs Have Evolved Since The '70sDrugs have become more lipophilic and complex in structure over time. Innovative strategies are needed to improve the bioavailability of these new drugs.
-
![West Pharma - Article 1 - 4040-40 Lyotec 13mm 20mm Group V2]( "Stopper Functionality – Key Considerations")
Stopper Functionality – Key ConsiderationsWhen selecting the appropriate rubber stopper for any respective vial containment system, there are many aspects to consider regarding the properties of the elastomeric closure.
-
![GettyImages-1264101698-lab-research-scientist]( "Formulation Development From Preclinical To First-In-Human")
Formulation Development From Preclinical To First-In-HumanA compound with poor biopharmaceutical properties or improper formulation design could lead to a delay in the project or even program termination.
-
![Wooden blocks PFAS-GettyImages-2145498657]( "PFAS In Medical Devices: Expert Insights On Frequently Asked Questions")
PFAS In Medical Devices: Expert Insights On Frequently Asked QuestionsWatch to learn more about PFAs in medical devices, covering environmental concerns, health risks, testing, alternatives and management strategies with Shalene Thomas of Battelle.
-
Streamline Your Fill And Finish Process Of Ready-To-Use Cartridges
An optimized nest design for pre-fillable cartridges was designed using numerical simulation and data analytics to improve efficiency in pharmaceutical production.
-
![GettyImages-2161651129_elderly pharmacy]( "A Taste Masked And Easily Swallowed Malaria Drug For Elderly Patients")
A Taste Masked And Easily Swallowed Malaria Drug For Elderly PatientsDysphagia impacts treatment compliance and disproportionately affects the elderly. Learn how microencapsulation enabled formulation of a water-soluble powder drives patient adherence.
-
![GettyImages-1302254900_nasal anatomy]( "White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges")
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And ChallengesExplore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
![Nasal Spray GettyImages-994129536]( "Key Considerations For Dry Powder Inhalation")
Key Considerations For Dry Powder InhalationA focus on spray-drying expertise in pulmonary and nasal powder development highlights why it is vital to choose the right CDMO.
-
![Baby eating]( "Delivering Child-Friendly, Broad-Range Dosing For Toddlers")
Delivering Child-Friendly, Broad-Range Dosing For ToddlersA European-based pharmaceutical company wanted to improve their pancreatic enzyme product (PEP) delivery to patients who have difficulty swallowing several capsules a day – especially children with cystic fibrosis and other conditions.
-
![GettyImages-1087218944 Scientists In Sterile Suits Working With Computers In The Laboratory]( "Meet Regulation Requirements With RTU Vials And Cartridges")
Meet Regulation Requirements With RTU Vials And CartridgesSterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![111Delivered-_by-_DeGrazio_Logo_Color_1]( "4 Opportunities For Advancing Drug Delivery")
4 Opportunities For Advancing Drug DeliveryIn this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
